Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
TXG 10x Genomics
- 12.315
- +0.375+3.14%
Close Feb 14 16:00 ET
- 12.400
- +0.085+0.69%
Post 20:01 ET
1.51BMarket Cap-8.10P/E (TTM)
13.070High11.865Low4.36MVolume12.010Open11.940Pre Close54.64MTurnover4.15%Turnover RatioLossP/E (Static)122.30MShares48.42052wk High2.12P/B1.29BFloat Cap10.80052wk Low--Dividend TTM104.95MShs Float208.990Historical High--Div YieldTTM10.09%Amplitude10.800Historical Low12.537Avg Price1Lot Size
About 10x Genomics Company
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Company Profile
SymbolTXG
Company Name10x Genomics
Listing DateSep 12, 2019
Issue Price39.00
Founded2012
CEODr. Serge Saxonov, PhD
MarketNASDAQ
Employees1306
Fiscal Year Ends12-31
Address6230 Stoneridge Mall Road
CityPleasanton
ProvinceCalifornia
CountryUnited States of America
Zip Code94588
Phone1-925-401-7300
Websitehttp://www.10xgenomics.com
Company Executives
- Name
- Position
- Salary
- Dr. Serge Saxonov, PhD
- Chief Executive Officer and Director
- 8.29M
- Eric S. Whitaker
- Chief Legal Officer
- 3.88M
- Mennah Moustafa
- Chief Commercial Officer
- --
- Dr. Benjamin J. Hindson, PhD
- Director, Chief Scientific Officer and President
- 4.43M
- Adam S. Taich
- Chief Financial Officer and Principal Accounting Officer
- --
- John R. Stuelpnagel, D.V.M.
- Chairman of the Board
- 403.59K
- Dr. Sarah A. Teichmann
- Director
- --
- Alan V. Mateo
- Director
- --
- Kimberly J. Popovits
- Independent Director
- 338.71K
- Sridhar Kosaraju
- Independent Director
- 346.39K
- Dr. Shehnaaz Suliman, M.D.
- Independent Director
- 336.39K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.